glp1 gip tirzepatide Effects of tirzepatide, a dual and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats hormone GLP Compounded GLP-1/GIP (3 Month) –

They are black market operations with good web design

Starting at a higher dose is technically off-label but is commonly used in specialist obesity practice when switching from another GLP-1 medication

Unlike crash diets, this approach targets metabolic drivers, supporting steady progress over 12 to 16 weeks and beyond

But it is not the cheapest compounded option available

Some platforms blur this distinction in ways that could mislead buyers about what they're getting

Purpose-built for physicians Adults with obesity using tirzepatide maintain remarkable weight loss at 88 weeks Key takeaways: Adults with obesity receiving tirzepatide lost a mean 25.3% of body weight at 88 weeks in the SURMOUNT-4 trial